Home › Migraine › Florida › Tampa
Migraine clinical trials in Tampa, FL
6 studies for Migraine are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of EVO756 in Adults With Migraine
RecruitingPhase 2
- Vantage Clinical Trials, Tampa
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
RecruitingPhase 3
- Santos Research Center, CORP, Tampa
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RecruitingPhase 3
- University of South Florida- Neuroscience Institute /ID# 229324, Tampa
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
RecruitingPhase 3
- University of South Florida, Tampa
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
RecruitingPhase 2
- Santos Research Center, Corp - Tampa, Tampa
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
RecruitingPhase 4
- Upsher-Smith Clinical Trial Site #14, Tampa
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Philadelphia, PA8 studies
- Concord, CA8 studies
- Amherst, NY7 studies
- Omaha, NE7 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Aurora, CO6 studies
- Stamford, CT6 studies
- San Diego, CA6 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer33 studies
- Metastatic Cancer29 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Pancreatic Cancer26 studies
- Ovarian Cancer21 studies
- Myelodysplastic Syndromes19 studies
- Melanoma19 studies
- Heart Failure18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.